|
|
Design Of An Antismoking Pill
More than two-thirds of the U.S.’s nearly 50 million smokers want to quit smoking—but only about 5% of those who try actually manage to kick the habit cold turkey, according to estimates from the Centers for Disease Control & Prevention. Pfizer is hoping that varenicline, a smoking-cessation agent now in late-stage Phase III clinical trials, could improve quitters’ chances. Viagra.
Read more about Design Of An Antismoking Pill
Generic Viagra Articles
Back to articles
|
|
